Skip to main content
SpringerLink
Log in

Effect of uric-acid-lowering therapy on progression of chronic kidney disease: A meta-analysis

  • Published:
Journal of Huazhong University of Science and Technology [Medical Sciences] Aims and scope Submit manuscript

Summary

The efficacy and safety of uric-acid-lowering therapy (UALT) on slowing the progression of chronic kidney disease (CKD) accompanied by hyperuricemia were assessed. We searched Cochrane Library, PubMed, EMbase, CNKI, Wanfang and Vip databases up to November 15, 2012 for randomized controlled trials (RCTs) which compared the effect of UALT to control therapy in hyperuricemic patients secondary to CKD, and then performed quality evaluation and meta-analysis on the included studies. Seven RCTs involving 451 cases were included. UALT delayed the increase of serum creatinine (MD=−62.55 μmol/L, 95% CI: −98.10 to −26.99) and blood urea nitrogen (MD= −6.15 mmol/L, 95% CI: −8.17 to −4.13) as well as the decrease of glomerular filtration rate [MD=5.65 mL/(min·1.73 m2), 95% CI: 1.88 to 9.41], decreased systolic blood pressure (SBP) (MD= −6.08 mmHg, 95% CI: −11.67 to −0.49), and reduced the risk of the renal disease progression (RR=0.30, 95% CI: 0.19 to 0.46). However, there was no statistically significant difference in 24-h urinary protein quantity and diastolic blood pressure (P>0.05). We identified that UALT could delay the progression of CKD with secondary hyperuricemia. And this also indirectly proved that hyperuricemia was a risk factor for the CKD progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Schlesinger N, Moore DF, Sun JD, et al. A survey of current evaluation and treatment of gout. J Rheumatol, 2006,33(10):2050–2052

    PubMed  Google Scholar 

  2. Nakaya I, Namikoshi T, Tsuruta Y, et al. Management of asymptomatic hyperuricemia in patients with chronic kidney disease by Japanese nephrologists: A questionnaire survey. Nephrology (Carlton), 2011,16(5):518–521

    Article  Google Scholar 

  3. Sonoda H, Takase H, Dohi Y, et al. Uric acid levels predict future development of chronic kidney disease. Am J Nephrol, 2011,33(4):352–357

    Article  CAS  PubMed  Google Scholar 

  4. Ben-Dov IZ, Kark JD. Serum uric acid is a GFR-independent long-term predictor of acute and chronic renal insufficiency: the Jerusalem Lipid Research Clinic cohort study. Nephrol Dial Transplant, 2011,26(8):2558–2566

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Chang HY, Tung CW, Lee PH, et al. Hyperuricemia as an independent risk factor of chronic kidney disease in middle-aged and elderly population. Am J Med Sci, 2010, 339(6):509–515

    PubMed  Google Scholar 

  6. Bellomo G, Venanzi S, Verdura C, et al. Association of uric acid with change in kidney function in healthy normotensive individuals. Am J Kidney Dis, 2010,56(2):264–272

    Article  CAS  PubMed  Google Scholar 

  7. Satirapoj B, Supasyndh O, Chaiprasert A, et al. Relationship between serum uric acid levels with chronic kidney disease in a Southeast Asian population. Nephrology (Carlton), 2010,15(2):253–258

    Article  CAS  Google Scholar 

  8. Tomita M, Mizuno S, Yamanaka H, et al. Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers. J Epidemiol, 2000,10(6):403–409

    Article  CAS  PubMed  Google Scholar 

  9. Higgins J, Altman DG. Assessing risk of bias in included studies. In: Higgins J, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions 5.0.1. Oxford: Cochrane Collaboration, 2008.

    Chapter  Google Scholar 

  10. Siu YP, Leung KT, Tong MK, et al. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis, 2006,47(1):51–59

    Article  CAS  PubMed  Google Scholar 

  11. Liu J, Sheng D. Allopurinol in lowering serum uric acid level for the delay of the progression of chronic renal disease. China Pharmac, 2007,18(32):2524–2525

    Google Scholar 

  12. Zhou DY, Zhao YJ, Xiao X, et al. Treatment of hyperuricemia in chronic kidney disease patients and its effect. Mod Med J China (Chinese), 2009,11(7):36–39

    Google Scholar 

  13. Lei J, Li ST. Clinical research on allopurinol lowering of uric acid level of chronic renal disease patients for the delay of the progression of renal disease. Shanxi Med J (Chinese), 2009,38(9):1191–1192

    CAS  Google Scholar 

  14. Deng YH, Zhang P, Liu H, et al. Research on lowering serum uric acid with allopurinol to delay the progression of chronic kidney disease. J Pract Med (Chinese), 2010,26(6):982–984

    CAS  Google Scholar 

  15. Shen H, Liu DY. Clinical research on allopurinol in lowering serum uric acid level for the delay of the progression of chronic renal disease. China Foreign Med Treat (Chinese), 2010,13(12):88–89

    Google Scholar 

  16. Goicoechea M, de Vinuesa SG, Verdalles U, et al. Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol, 2010,5(8):1388–1393

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Pacher P, Nivorozhkin A, Szabó C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev, 2006,58(1):87–114

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Chonchol M, Shlipak MG, Katz R, et al. Relationship of uric acid with progression of kidney disease. Am J Kidney Dis, 2007,50(2):239–247

    Article  CAS  PubMed  Google Scholar 

  19. Ruilope LM, Garcia-Puig J. Hyperuricemia and renal function. Curr Hypertens Rep, 2001,3(3):197–202

    Article  CAS  PubMed  Google Scholar 

  20. Jaramillo M, Godbout M, Naccache PH, et al. Signaling events involved in macrophage chemokine expression in response to monosodium urate crystals. J Biol Chem, 2004,279(50):52 797–52 805

    Article  CAS  Google Scholar 

  21. Sancher-Lozada LG, Tapia E, Santamaria J, et al. Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int, 2005,67(1):237–247

    Article  Google Scholar 

  22. Kang DH, Nakagawa T, Feng L, et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol, 2002,13(12):2888–2897

    Article  CAS  PubMed  Google Scholar 

  23. Convento MS, Pessoa E, Dalboni MA, et al. Pro-inflammatory and oxidative effects of noncrystalline uric acid in human mesangial cells: contribution to hyperuricemic glomerular damage. Urol Res, 2011,39(1):21–27

    Article  CAS  PubMed  Google Scholar 

  24. Kanellis J, Watanabe S, Li JH, et al. Uric acid stimulates MCP-1 production in vascular smooth muscle cells via MAPK and COX-2. Hypertension, 2003,41(6):1287–1293

    Article  CAS  PubMed  Google Scholar 

  25. Roncal CA, Mu W, Croker B, et al. Effect of elevated serum uric acid on cisplatin-induced acute renal failure. Am J Physiol Renal Physiol, 2007,292(1):F116–F122

    CAS  PubMed  Google Scholar 

  26. Karbowska A, Boratynska M, Kusztal M, et al. Hyperuricemia is a mediator of endothelial dysfunction and inflammation in renal allograft recipients. Transplant Proc, 2009,41(8):3052–3055

    Article  CAS  PubMed  Google Scholar 

  27. Sánchez-Lozada LG, Tapia E, Avila-Casado C, et al. Mild hyperuricemia induces glomerular hypertension in normal rats. Am J Physiol Renal Physiol, 2002,283(5):F1105–F1110

    PubMed  Google Scholar 

  28. Khosla UM, Zharikov S, Finch JL, et al. Hyperuricemia induces endothelial dysfunction. Kidney Int, 2005,67(5):1739–1742

    Article  PubMed  Google Scholar 

  29. Mazzali M, Kanellis J, Han L, et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol, 2002,282(6):F991–F997

    CAS  PubMed  Google Scholar 

  30. Watanabe S, Kang DH, Feng L, et al. Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension, 2002,40(3):355–360

    Article  CAS  PubMed  Google Scholar 

  31. Corry DB, Eslami P, Yamamoto K, et al. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens, 2008,26(2):269–275

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nephrology, Huazhong University of Science and Technology, Wuhan, 430030, China

    Ye-fang Zhang  (张叶芳), Fan He  (何 凡), Wei Dai  (代 维), Qian Zhang  (张 茜), Hong Luan  (栾 宏), Yong-man Lv  (吕永曼) & Hong-bing Zeng  (曾红兵)

  2. Department of Ultrasonography, Huazhong University of Science and Technology, Wuhan, 430030, China

    Ye-fang Zhang  (张叶芳)

  3. Division of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China

    Hong-hui Ding  (丁红晖)

Authors
  1. Ye-fang Zhang  (张叶芳)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fan He  (何 凡)
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hong-hui Ding  (丁红晖)
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wei Dai  (代 维)
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Qian Zhang  (张 茜)
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hong Luan  (栾 宏)
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yong-man Lv  (吕永曼)
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hong-bing Zeng  (曾红兵)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Yong-man Lv  (吕永曼) or Hong-bing Zeng  (曾红兵).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, Yf., He, F., Ding, Hh. et al. Effect of uric-acid-lowering therapy on progression of chronic kidney disease: A meta-analysis. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 34, 476–481 (2014). https://doi.org/10.1007/s11596-014-1302-4

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-014-1302-4

Key words

Search

Navigation